Non-stimulants like atomoxetine may have different effects, often with less initial appetite suppression but still potential for weight changes due to metabolic or behavioral shifts
While these agents are generally well-tolerated, rare instances of hepatotoxicity, including liver tests elevations, cholestatic hepatitis, acute liver injury and autoimmune-like hepatitis have been reported, in some cases contributing to discontinuation of further clinical development
Let us help you achieve your goals with GLP-1 Agonist
Patients with genetic variants linked to altered nutrient absorption may benefit from more frequent B12 monitoring or proactive intramuscular dosing from treatment onset, rather than waiting for symptomatic depletion
Le Melanotan-2 est-il associ des cas de mlanome
Even if initially denied, over 65% of prior authorization appeals succeed